These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3987077)

  • 41. Creatine phosphokinase levels in the newborn and their use in screening for Duchenne muscular dystrophy.
    Drummond LM
    Arch Dis Child; 1979 May; 54(5):362-6. PubMed ID: 475411
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum creatine kinase activity and carrier status for duchenne muscular dystrophy.
    Bullock DG; McSweeney FM; Whitehead TP; Edwards JH
    Lancet; 1979 Dec 22-29; 2(8156-8157):1370. PubMed ID: 92710
    [No Abstract]   [Full Text] [Related]  

  • 43. Computed tomographic patterns of pseudohypertrophic muscular dystrophy: preliminary results.
    O'Doherty DS; Schellinger D; Raptopoulos V
    J Comput Assist Tomogr; 1977 Oct; 1(4):482-6. PubMed ID: 615228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) in female relatives and patients with X-linked muscular dystrophies (Duchenne and Becker).
    Zatz M; Shapiro LJ; Campion DS; Kaback MM; Otto PA
    J Neurol Sci; 1980 Jun; 46(3):267-79. PubMed ID: 7381516
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Asymptomatic hyperCKemia: detection of an isolated carrier of Duchenne muscular dystrophy.
    Tachi N; Wakai S; Yutoh Y; Chiba S; Miura J
    J Child Neurol; 1990 Oct; 5(4):351-3. PubMed ID: 2246492
    [No Abstract]   [Full Text] [Related]  

  • 46. [Distribution of skeletal muscle involvement in autosomal recessive distal muscular dystrophy: a clinical and computed tomographic study].
    Mizusawa H; Kobayashi F; Nakanishi T
    Rinsho Shinkeigaku; 1987 Feb; 27(2):177-84. PubMed ID: 3581592
    [No Abstract]   [Full Text] [Related]  

  • 47. [Computed tomography in Duchenne type muscular dystrophy--morphological stages based on the computed tomographical findings].
    Kawai M; Kunimoto M; Motoyoshi Y; Kuwata T; Nakano I
    Rinsho Shinkeigaku; 1985 May; 25(5):578-90. PubMed ID: 4028577
    [No Abstract]   [Full Text] [Related]  

  • 48. Carrier detection in Duchenne muscular dystrophy.
    Carter CO
    Lancet; 1979 May; 1(8123):979. PubMed ID: 87648
    [No Abstract]   [Full Text] [Related]  

  • 49. [Muscle CT in Duchenne muscle dystrophy in infants].
    Takahashi R; Matsui K; Fukushima N; Kurokawa T
    No To Hattatsu; 1992 Sep; 24(5):496-8. PubMed ID: 1389336
    [No Abstract]   [Full Text] [Related]  

  • 50. A new method for the analysis of age trends in CPK levels with application to Duchenne muscular dystrophy.
    Lange K; Zatz M
    Hum Hered; 1979; 29(3):154-60. PubMed ID: 468274
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of carriers of X-linked gene for Duchenne muscular dystrophy by levels of creatine kinase and pyruvate kinase.
    Falcão-Conceição DN; Gonçalves-Pimentel MM; Baptista ML; Ubatuba S
    J Neurol Sci; 1983 Dec; 62(1-3):171-80. PubMed ID: 6668472
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Needle muscle biopsy for carrier detection in Duchenne muscular dystrophy. Part 1. Light microscopy--histology, histochemistry and quantitation.
    Maunder-Sewry CA; Dubowitz V
    J Neurol Sci; 1981 Feb; 49(2):305-24. PubMed ID: 6452514
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Duchenne muscular dystrophy. Use of rubidium chloride Rb 86 in the detection of carriers of the gene.
    Bradley WG; Gardner-Medwin D; Haggith J; Walton JN; Hesp R
    Arch Neurol; 1971 Sep; 25(3):193-7. PubMed ID: 4951942
    [No Abstract]   [Full Text] [Related]  

  • 54. Carrier detection in Duchenne muscular dystrophy. Evidence from a study of obligatory carriers and mothers of isolated cases.
    Sibert JR; Harper PS; Thompson RJ; Newcombe RG
    Arch Dis Child; 1979 Jul; 54(7):534-7. PubMed ID: 485196
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carrier detection in X-linked recessive (Duchenne) muscular dystrophy: serum creatine phosphokinase values in premenarchal, menstruating, postmenopausal and pregnant normal women.
    Smith I; Elton RA; Thomson WH
    Clin Chim Acta; 1979 Nov; 98(3):207-16. PubMed ID: 498534
    [No Abstract]   [Full Text] [Related]  

  • 56. [Mechanism to induce scoliosis in Duchenne muscular dystrophy--a study of paraspinal muscle by X-ray computed tomography].
    Ando N; Takayanagi T; Fujimoto Y; Mano Y
    Rinsho Shinkeigaku; 1992 Sep; 32(9):956-61. PubMed ID: 1300267
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activity of creatine kinase in sera from healthy women, carriers of Duchenne muscular dystrophy and cord blood, determined by the "European" recommended method with NAC-EDTA activation.
    Moss DW; Whitaker KB; Parmar C; Heckmatt J; Wikowski J; Sewry C; Dubowitz V
    Clin Chim Acta; 1981 Oct; 116(2):209-16. PubMed ID: 6794955
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Skeletal muscle MRI findings in autosomal recessive distal muscular dystrophy (Miyoshi)].
    Ohsuga H; Ohsuga S; Yamamoto M; Shinohara Y
    Rinsho Shinkeigaku; 1988 Nov; 28(11):1304-11. PubMed ID: 3233830
    [No Abstract]   [Full Text] [Related]  

  • 59. Carrier detection in Duchenne muscular dystrophy. A comparative study of electron microscopy, light microscopy and serum enzymes.
    Roy S; Dubowitz V
    J Neurol Sci; 1970 Jul; 11(1):65-79. PubMed ID: 5451354
    [No Abstract]   [Full Text] [Related]  

  • 60. [A case of an 8-year-old girl, a symptomatic carrier of Duchenne's muscular dystrophy].
    Kurihara M; Imai Y; Kumagai K; Hasegawa H; Nonaka M
    No To Hattatsu; 1990 Jul; 22(4):394-6. PubMed ID: 2400617
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.